Please login to the form below

Not currently logged in
Email:
Password:

WHO appoints two regional directors

Dr Poonam Khetrapal Singh and Dr Shin Young-soo to head major areas
Poonam Khetrapal Singh, WHO

The World Health Organization (WHO) has named two regional directors.

Dr Poonam Khetrapal Singh (top right) is appointed the new WHO regional director for South East Asia and Dr Shin Young-soo (bottom right) is re-appointed WHO regional director for the Western Pacific.

Dr Khetrapal Singh, who takes up her new role on February 1, was most recently deputy regional director for the South-East Asia.

She succeeds Dr Samlee Plianbangchang who spent 10 years in charge of the WHO's operations in South East Asia.

Dr Khetrapal Singh has an extensive career in health and public affairs in Asia. This includes time as health secretary of the Punjab region in India.

She then moved to the health, population and nutrition department of the World Bank before joining WHO in 1998 as executive director in director-general Dr Gro Harlem Brundtland's cabinet in Geneva.

“We will focus on promoting universal health coverage, robust health systems and strengthening emergency risk management in South East Asia,” said Khetrapal Singh. “I am committed to an excellence pursuing, responsive and accountable WHO in the region."

Shin Young-soo, WHODr Shin was originally appointed regional director for the Western Pacific in 2009, having previously served with the government of South Korea in the ministry of health and welfare.

During his first four-year term the Western Pacific region achieved several accomplishments including reducing levels of measles and hepatitis B and improving preparedness for public health emergencies.

29th January 2014

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics